ASX:ACW

Actinogen Medical Ltd - ACW share price

$ - -

About Actinogen Medical Ltd

Actinogen Medical Limited, formerly Actinogen Limited, is a clinical-stage biotechnology company. The Company focuses on the treatment of Alzheimer's disease and age-related neurodegenerative diseases. The Company is engaged in treating cognitive impairment in chronic neurodegenerative diseases through the inhibition of cortisol production. The Company's Xanamem is a drug under development for the treatment of Alzheimer's disease, which is designed to block the production of cortisol in the brain. Xanamem's mechanism of action is to block the activity of a specific enzyme in the brain, the 11B-HSD1 enzyme. It focuses on Xanamem in the clinical areas, including Diabetes-Cognitive dysfunction, Cognitive dysfunction in Parkinson's Disease, Post Traumatic Stress Disorder (PTSD), Cognitive dysfunction in schizophrenia and depression, and Cardiovascular disease-Post myocardial infarction. It focuses on Phase II XanADu efficacy and safety study with mild Alzheimer's disease patients.

Company Profile

Market Cap -

Book Value -

Enterprise Value -

Revenue TTM -

Shares Outstanding -

Earning Share

Shares Float -

Dividend per Share

P/E Ratio -

Div Yield -

Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.

Price Summary

Today's Low Today's High

- -

52 Week High

52 Week Low

Price Chart (ACW)

TOP ASX STOCKS Worth Watching

✓ Instant Access
✓ No Credit Card Required
✓ Free to join · No spam

Get Free Report on WhatsApp

Free to join · No spam · Unsubscribe anytime

Special Research Report

Discover the Top ASX Stocks to Invest in 2026!

Expert Analysis of Top-Performing ASX Stocks

Market Insights and In-Depth Research

Buy, Sell, And Hold Recommendations

Almost There!

Enter your details to download the report

Full Name

Email Address

Phone Number

By providing your details, you agree to Veye’s Terms & Conditions, Privacy Policy, and Financial Services Guide and to receive marketing offers by email, text message or phone call from us or our agents until you opt out. Before you access our services, please read the Financial Service Guide available here.